March 17, 2022
Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M Seed to Develop Repairing-Based Approaches to Reversing Aging
Kizoo portfolio company Revel Pharmaceuticals has raised $8.4M in Seed financing. The oversubscribed round was led by Kizoo Technology Capital and Starbloom Capital with participation from Tubus LLC. The funds will support Revel as it advances its repair-based enzyme therapy pipeline towards the clinic.